Introduction {#S0001}
============

Chronic alcohol overconsumption is an important cause of impaired health, ^[1](#CIT0001)^ and changes in gut microbiota have been suggested as a key factor in the development of alcohol-related morbidity.^[2](#CIT0002),[3](#CIT0003)^ However, as pointed out in a recent review by Hillemacher et al., ^[4](#CIT0004)^ clinical studies of gut microbiota in alcohol-dependent humans have hitherto been sparse.

The gut microbiota may be evaluated either by assessing its composition or by measuring its functions. The composition seems to be host-specific, develops from birth and throughout the lifespan, ^[5](#CIT0005)^ and is affected by external factors like diet, surgery and the use of antibiotics.^[6](#CIT0006)^ Alcohol consumption may also influence the composition, ^[7](#CIT0007)^ consequently affecting gut microbiota functions. Assessing microbial metabolites, such as short-chain fatty acids (SCFAs), may offer a way to evaluate such functions. SCFAs are products of fermentation of unabsorbed food residues (mainly carbohydrates) within the colon, and around 95% of the SCFAs are absorbed and used as an energy source for the host.^[8](#CIT0008)^ SCFAs may also play an important role in the communication between the gut microbiota and other parts of the body.^[8](#CIT0008)--[10](#CIT0010)^ Although the excretion of SCFAs is complex, the production seems to be regulated and is dependent on bacteria.^[8](#CIT0008)^ Thus, assessment of SCFAs is a recognized measure of gut microbiota function.

Using ^13^C-D-xylose breath tests, our group has previously demonstrated differences between patients with high and low alcohol consumption, findings that suggest small intestinal malabsorption and alterations of colonic microbiota as a consequence of alcohol overconsumption.^[11](#CIT0011)^ In the present study, we aimed to explore these observations further, by investigating gut microbiota composition and functions in subjects with chronic alcohol overconsumption.

Results {#S0002}
=======

Participants {#S0002-S2001}
------------

Data were available from 24 patients with chronic alcohol overconsumption and 18 patients in the control group. The groups were similar regarding age and gender ([Table 1](#T0001)). We found no significant difference in pancreatic, renal or hepatic function tests as assessed by faecal or blood samples. The group of active alcohol overconsumers had an average alcohol consumption of 118.9 g/day, versus 2.5 g/day in the control group. All control patients and half of the patients in the group of alcohol overconsumers were included during Hospital admittance. The rest were included from the substance abuse-project accounted for in the Patients and Methods section. The main reasons for patients not being eligible for inclusion from this group are summarized in [Figure 1](#F0001). Among patients included during Hospital admittance, the most common diagnoses or symptoms leading to admittance were atrial fibrillation, transitory ischemic attack and chest pain. Twenty-six patients (11 alcohol overconsumers and 15 control patients) were initially included in the study, but had to be excluded due to lack of faecal sample.10.1080/19490976.2019.1580097-T0001Table 1.Baseline characteristics and nutritional screening results for patients with ongoing alcohol overconsumption (*n* = 24) and control patients (*n* = 18).  Alcohol overconsumersControl Group Variable (*n* = 24)(*n* = 18)*P*-valueMale*n* (%)19 (79)14 (77) Age (years)mean (range)64.8 (43--85)58.2 (34--78)0.076BMI (kg/m^2^)mean (SD)27.0 (4.4)28.4 (4.0)0.232Muscle mass (kg)mean (SD)26.3 (5.9)27.2 (5.5)0.614Handgrip strength (kg)mean (SD)29.8 (10.8)38.1 (10.4)0.019Alcohol intake (g/day)mean (SD)118.9 (93.4)2.5 (2.9)\<0.001Vitamin A (μmol/L)mean (SD)2.4 (1.0)2.3 (0.4)0.729Vitamin B~1~ (nmol/L)mean (SD)183.1 (66.5)158.8 (30.9)0.139Folate (nmol/L)mean (SD)23.5 (10.9)19.8 (6.2)0.176Vitamin B~12~ (pmol/L)mean (SD)458.0 (286.3)473.7 (250.7)0.854Vitamin C (µmol/L)mean (SD)38.9 (22.7)60.7 (20.1)0.004Vitamin D (nmol/L)mean (SD)50.6 (26.3)55.2 (23.4)0.568MNA ^1^ (total score)mean (SD)24.3 (3.3)26.9 (2.4)0.006Sodium (mmol/L)mean (SD)137.8 (4.9)141.4 (1.7)0.002Magnesium (mmol/L)mean (SD)0.78 (0.2)0.86 (0.1)0.029MCV (fL)mean (SD)98.5 (7.2)90.9 (3.4)\<0.001Pancreas insufficiency^2^n (%)2 (11)3 (12.5)1.000[^1] 10.1080/19490976.2019.1580097-F0001Figure 1.Flow chart of inclusion process.

There was no significant difference between the groups regarding weight, height, BMI, muscle mass or body fat ([Table 1](#T0001)). Low muscle mass index was common in both groups (91 vs 78%), while handgrip strength was significantly lower among alcohol overconsumers. This group scored significantly lower on the MNA test compared to the control group. Sub-scores for "reduced appetite," "few daily meals" and "depression" were the main reasons for the higher MNA scores in the control group (data not shown). Alcohol overconsumers had significantly lower levels of vitamin C, magnesium and sodium, and higher MCV compared to the control group ([Table 1](#T0001)). Vitamin C deficiency defined as plasma level \<30 µmol/L, was found exclusively in the group of patients with alcohol overconsumption (30%), while one patient in this group had vitamin A deficiency (\<0.7 µmol/L). Vitamin B supplements were frequently used, and deficiency of thiamine (\<70 nmol/L), folate (\<6 nmol/L) or B~12~ (\<160 pmol/L) was not present. Vitamin D deficiency defined as 25(OH) Vitamin D\< 50 nmol/L was present among 44%, and there were no differences between the groups.

The use of medication, such as beta-blockers, statins, and acetyl salicylic acid was similar in the two groups. A higher proportion of alcohol overconsumers were treated with proton pump inhibitors (8, versus 2 in the control group). However, we found no difference in abundance of *Proteobacteria, Holdemania, Clostridium, Faecalibacterium* or *Sutterella*, when comparing patients with proton pump inhibitors, to those without.

Sequencing, mapping, and counting of gut microbiota composition {#S0002-S2002}
---------------------------------------------------------------

After sequence read filtering, 64000 reads per sample were obtained and used for operational taxonomic unit (OTU) construction. The sequencing depths achieved were sufficient to evaluate the bacterial diversity in all samples, as evaluated by rarefaction plots (data not shown).

Using the Shannon alpha-diversity measurement, we found no average difference between alcohol overconsumers and control patients (Shannon median score 5.81 and 5.74 for controls and alcohol overconsumers).

Using UniFrac values calculated from the normalized OTU count table, we found no trends using the weighted algorithm. However, the qualitative approach identified a sub-cohort of alcohol overconsumers with a different microbiome composition than control patients. In addition, testing for differences between groups showed significant differences both using the weighted (p = 0.003, Tukey's HSD test) and unweighted (p = 0.002, Tukey's HSD test) algorithm.

Relative abundance analysis {#S0002-S2003}
---------------------------

We focused our analyses of bacterial taxa abundance on relative abundance at the phyla and genus level. At the phylum level, four phyla dominated ([Figure 2(a](#F0002))). Testing for differential abundance at phylum level showed that alcohol overconsumers had a significantly higher relative abundance of *Proteobacteria* ([Figure 2(b](#F0002)), median value 0.02 (IQR 0.021) and 0.009 (IQR 0.018), p = 0.013, Mann--Whitney U-test). We found no significant difference among the other phyla present (*Firmicutes, Bacteroidetes, Actinobacteria*). We found no dose-dependent relationship between the amount of alcohol consumption and *Proteobacteria. Firmicutes: Bacteroidetes* ratio was similar in the groups (median 0.88 and 0.81, respectively; p = 0.22, Mann-Whitney U test).10.1080/19490976.2019.1580097-F0002Figure 2.Relative bacterial composition at the phylum level. (a) Pie charts depicting the average relative abundance for major phyla for alcohol overconsumers (n = 24) and controls (n = 18). (b) Relative abundance of *Proteobacteria* for alcohol overconsumers (n = 24) and controls (n = 18). The lines represent median values.

Testing for differential abundance at the genus level (including genera with an average relative abundance \>0.001) we found a lower relative abundance of *Faecalibacterium* in the group of alcohol overconsumers, and a higher relative abundance of *Sutterella, Clostridium*, and *Holdemania* ([Figure 3(a--d)](#F0003), Mann--Whitney U test). We found no significant correlations between the amount of alcohol consumption and these genera.10.1080/19490976.2019.1580097-F0003Figure 3.Differences in bacterial composition between alcohol overconsumers (n = 24) and controls (n = 18) at genus level. The lines represent median values. (a) *Faecalibacterium* levels. (b) *Clostridium* levels. (c) *Sutterella* levels. (d) *Holdemania* levels.

As a complementary and validating method to identify differentially expressed taxa, we applied linear discriminant analysis effect size (LEfSe)^[12](#CIT0012)^ ([Figure 4(a](#F0004))). First, we generated a bar plot of the effect size of taxa with differential relative abundance between alcohol overconsumers and controls ([Figure 4(a](#F0004))). Of note, we found that the effect size was large for phylum *Proteobacteria*, and all genera previously found to have a different relative level were also identified in this test. However, this strategy yielded additional candidates with different levels of abundance, including *Ruminococcaceae* and *Prevotella* (higher in controls). Secondly, we generated a cladogram to illustrate the relationship between different taxa ([Figure 4(b](#F0004))). This figure also shows a higher relative abundance of *Proteobacteria*, and illustrated that this difference was partly due to the families *Enterobactericaea* and *Desulfovibrionaceae*. We also observed a lower relative abundance of several taxonomic groups within the *Firmicutes* phylum, in particular the class *Clostridia*. Furthermore, in this test *Actinobacteria* was also found to be at the lower relative expression in alcohol overconsumers relative to controls.10.1080/19490976.2019.1580097-F0004Figure 4.Cross-taxa validation and functional characterization of gut microbiota in alcohol overconsumers (n = 24) and controls (n = 18), where green color indicates taxa enriched (**↑**) in alcohol overconsumers, and red color indicates taxa depleted (**↓**) in alcohol overconsumers. (a) Taxa with statistical different relative levels between alcohol overconsumers (n = 24) and controls (n = 18), with effect size, across all taxa. (b) Cladogram showing phylogenetic relationships between taxa that are statistically different. (c) Barchart with KEGG orthology functional terms identified by PICRUSt as different in alcohol overconsumers (n = 24) and controls (n = 18).

Short-chain fatty acids (SCFAs) {#S0002-S2004}
-------------------------------

For butyric acid, we found a lower percentage (11.9% versus 16.3%, p = 0.012, Mann Whitney U-test) and a tendency towards a lower concentration (3.9 mmol/kg vs 5.6 mmol/kg, p = 0.054, Mann Whitney U-test) in faecal samples of alcohol overconsumers, than in samples from the control patients. Concentration and percentage of the other SCFAs, and the total amount of SCFAs were similar in the two groups ([Table 2](#T0002)). In alcohol overconsumers, *Protebacterium* abundance correlated inversely with butyric acid levels (Spearman\`s rho = −0.61, p = 0.002), acetic acid levels (Spearman\`s rho = −0.48, p = 0.02), valeric acid levels (Spearman\`s rho = −0.45, p = 0.03) and total amount of SCFAs (Spearman\`s rho = −0.53, p = 0.008). We found a positive correlation between *Faecalibacterium* abundance and concentration of butyric acid (Spearman\`s rho = 0.4, p = 0.05), and an inverse correlation with iso-butyric acid (Spearman\`s rho = −0.45, p = 0.03) and iso-valeric acid (Spearman\`s rho = −0.49, p = 0.014). For *Sutterella, Holdemania*, and *Clostridium*, we found no significant correlations with SCFAs.10.1080/19490976.2019.1580097-T0002Table 2.Concentrations of short chain fatty acids (SCFAs), measured in mmol/kg (median, min -- max) and percentage of total amount (median, min -- max).SCFA concentration (mmol/kg)Alcohol overconsumers\
(*n* = 24)Control Group\
(*n* = 18)*P*-valueAcetic acid17.6 (6.8--44.2)23.0 (13.8--49.0)0.113% of total SCFA concentration60.3 (44.7--73.0)60.4 (49.3--74.8)0.811Propionic acid4.9 (1.7--18.9)6.6 (2.0--14.3)0.678% of total SCFA concentration15.7 (10.0--35.4)15.0 (4.1--26.0)0.442Iso-butyric acid0.6 (0.2--3.5)0.8 (0.14--3.3)0.166% of total SCFA concentration2.3 (0.6--4.9)2.1 (0.2--4.6)0.831Butyric acid4.1 (1.2--24.8)5.6 (3.3--20.6)0.054% of total SCFA concentration12.1 (6.9--27.9)16.3 (11.5--22.4)0.012\*Iso-valeric acid0.7 (0.25--5.0)1.0 (0.1--4.8)0.253% of total SCFA concentration2.8 (0.4--7.1)2.7 (0.2--6.8)0.753Valeric acid0.9 (0.0--4.5)0.96 (0.0--4.4)0.965% of total SCFA concentration3.1 (0.0--10.1)2.4 (0.1--6.4)0.307Iso-capronic acid0.0 (0--0)0.0 (0.0--0.08)0.429% of total SCFA concentration0.0 (0--0)0.00 (0.0--0.16)0.429Capronic acid0.1 (0.0--1.6)0.13 (0.0--1.1)0.831% of total SCFA concentration0.14 (0.0--1.6)0.2 (0.0--1.1)0.609Total SCFA (mmol/kg)32.7 (11.1--93.5)37.7 (20.7--92.1)0.168

Predictive metagenomic analysis {#S0002-S2005}
-------------------------------

Using PICRUSt, we inferred the gene content of the microbiota based on the 16S rRNA sequences ([Figure 4(c](#F0004))). The inferred gene counts were merged into larger categories (level 3 KEGG orthology), based on their molecular function, involvement in disease, metabolic pathways or cellular function. Notably, we found that the gut microbiota of patients with alcohol overconsumption had relatively more bacteria containing genes for "Bacterial invasion of epithelial cells". A closer inspection revealed that a subset of these patients had very high counts (reaching up to \>4500 reads), while none of the controls had a read count \>350 (median 85). The observed difference was almost entirely determined by higher levels of genes in the adhesion/invasion gene category (K13735).

Discussion {#S0003}
==========

Diversity analyses indicated a difference in gut microbiota composition between patients with chronic alcohol overconsumption and controls with a history of no or low alcohol intake. At phylum level, patients with alcohol overconsumption had a higher relative abundance of *Proteobacteria*. They had a lower relative abundance of genus *Faecalibacterium*, and a higher relative abundance of the genera *Clostridium, Sutterella* and *Holdemania*. We found lower percentages and concentrations of butyric acid in alcohol overconsumers, while other SCFA-levels were similar in the groups.

Our results suggest that alcohol contributes to over-representation of *Proteobacteria* in the gut, consistent with previous studies on humans ^[2](#CIT0002)^ and rodents.^[13](#CIT0013)^ *Proteobacteria* seem to play an important role in the development of disease related to the gut microbiota.^[14](#CIT0014)^ They are endotoxin (lipopolysaccharide, LPS) containing, Gram-negative, facultative anaerobic rods. Among the quantitatively dominant phyla that comprise the gut microbiota, *Proteobacteria* is the most unstable over time, and some researchers have proposed it as a biomarker for dysbiosis.^[14](#CIT0014)^ In addition to serve as markers, they also possibly play a role in the development of diseases where a pro-inflammatory activation of the immune system in the intestines is vital for the pathophysiology.^[14](#CIT0014),[15](#CIT0015)^

A high relative abundance of genus *Faecalibacterium* like *Faecalibacterium prausnitzii* is generally believed to be protective against gastrointestinal, ^[16](#CIT0016)^ as well as extra-intestinal conditions.^[17](#CIT0017)^ In our study, the group of alcohol overconsumers had a lower relative abundance of bacteria from genus *Faecalibacterium* than the control patients did, consistent with previous studies.^[18](#CIT0018)^ Together with the increased relative abundance of *Proteobacteria*, this indicates a potentially more inflammatory active gut microbiota within this group.

We found higher relative abundance of genera *Sutterella* (*Proteobacteria), Holdemania* and *Clostridium* (both *Firmicutes*) in alcohol overconsumers. Previous studies have concluded that *Sutterella* species are possible pro-inflammatory agents.^[19](#CIT0019)^ Leclerq et al. discovered decreasing amounts of *Holdemania* and *Clostridium* (patients with high intestinal permeability) after three weeks of sobriety in patients with previous alcohol overconsumption.^[20](#CIT0020)^ Species from these genera may play a role in the pathophysiological development of other medical conditions, but this is presently unclear.

We found a lower percentage, and a tendency towards a lower concentration of butyric acid, in the feces of alcohol overconsumers. The concentrations and fractions of the other quantified SCFAs, and the total amount of SCFAs, were similar in the two groups. Further analyses revealed an inverse relation between *Proteobacteria* abundance, and concentrations of butyric acid, acetic acid, and the total amount of SCFAs. We also discovered a positive correlation between *Faecalibacterium*, and butyric acid levels. The composition of the gut microbiota is central for which SCFAs that are formed, and in which amount. SCFAs in general and butyric acid in particular, are important factors for the gut homeostasis, including the maintenance of the intestinal wall integrity.^[21](#CIT0021),[22](#CIT0022)^ The formation of butyric acid within the colon partly depends on species from the phylum *Firmicutes*, such as *Faecalibacterium prausnitzii*.^[21](#CIT0021)^ A high level of butyric acid is considered to be protective against the inflammatory activity, ^[23](#CIT0023)^ and low levels of this SCFA has been related to conditions such as Crohn's disease.^[24](#CIT0024)^ The impact of alcohol use on SCFA formation has been studied far more extensively in rodents than in humans. Xie et al. discovered that feeding with alcohol led to a decreased level of butyric acid in rats.^[25](#CIT0025)^ In a study in mice, butyrate supplementation protected against injurious effects of alcohol intake, on tight junctions and the liver.^[26](#CIT0026)^ In the light of this, the difference in butyric acid between the groups, and the relations between SCFAs and bacterial taxa, are intriguing. These findings may represent a possible physiological link between gut microbiota composition, and the harmful effects from alcohol overconsumption. However, due to the complexity of SCFA formation and its interplay with gut microbiota and the intestinal epithelium, these results must be interpreted cautiously, especially within the limits of a cross-sectional study design.

Predictive metagenome profiling may be used to evaluate inferred functional aspects of microbiomes.^[27](#CIT0027)^ Using PICRUSt, our study demonstrated several differences in such variables that may be of pathophysiological significance, but the findings are challenging to interpret and should be considered with caution. However, in the light of microbial differences pointing in a putative pro-inflammatory direction, the observed prevalence of genes related to bacterial invasion of epithelial cells is an intriguing functional culprit, possibly bridging microbial compositional differences and immunological consequences. In this scenario, the ability of bacteria to invade an epithelial cell and immune 'sensing' of potentially harmful bacteria may trigger an immune response, potentially associated with anxiety and depression.^[10](#CIT0010)^ However, in order to examine this further, we would need to perform functional analyses on the study subjects.

When evaluating nutritional aspects, we prioritized screening in terms of function instead of quantifying food-intake, such as using food frequency questionnaires. By examining anthropometric measures including several markers for sarcopenia, quantifying vitamins and minerals, and using the screening tool MNA, we got an overview of the patients\` overall nutritional risk. We found that the alcohol overconsumers had lower vitamin C-levels, sarcopenia as assessed by handgrip strength, and a lower overall MNA-score. Other biochemical and sarcopenia markers were similar in the two groups. Overall, the group of alcohol overconsumers seemed to have certain signs of an inadequate nutritional intake, and we cannot rule out that this is a factor in explaining parts of the microbiota-findings.

Strengths and limitations {#S0003-S2001}
-------------------------

The impact of long-term excessive alcohol ingestion on gut microbiota composition and functions has been sparsely studied in man, and the inclusion of a representative control group from the same clinical population as the cases, rather than recruiting healthy volunteers, is a unique feature of our study. The relatively small sample size, the lack of detailed information regarding dietary intake that might affect levels of bacteria and SCFAs, and detailed information regarding organ disease (although no patients with severe organ failures were included) that potentially might affect the gut microbiota, represent limitations of the study. Moreover, the choice of a cross-sectional design reduces the possibility of drawing causative conclusions. We also acknowledge that the recall-dependent method applied for quantification of alcohol use is a potential source of error.

Conclusion {#S0003-S2002}
----------

In conclusion, there seems to be an association between chronic alcohol overconsumption, and certain compositional and functional characteristics of the gut microbiota, which in alcohol overconsumers are skewed into a putative pro-inflammatory direction. The clinical impact and causal relation between alcohol use and these alterations should be investigated further, in the form of controlled experiments and longitudinal studies.

Patients and methods {#S0004}
====================

Participants {#S0004-S2001}
------------

We recruited patients from Lovisenberg Diaconal Hospital during two time periods ([Figure 1](#F0001)). First, from 2011 to 2013, a project was carried out at our hospital aiming to identify patients with potentially health-threatening substance abuse, for subsequent follow up after discharge (n = 355). The majority of this cohort of consecutively included patients had chronic alcohol overconsumption (n = 351; 259 males), and they were hence eligible for inclusion in the present study. Secondly, we asked consecutive patients admitted to the hospital during the inclusion period from September to December in 2014 to participate (n = 32; 24 males). The inclusion criteria were an ongoing or recent history of alcohol overconsumption of more than 20 or 40 g of alcohol per day for women and men.^[28](#CIT0028)--[30](#CIT0030)^ Exclusion criteria were conditions or treatments with a suspected influence on the gut microbiota. This included a history of abdominal surgery (except appendectomy), inflammatory bowel disease, gastrointestinal cancer, infectious gastroenteritis (last four weeks), or an ongoing or recent use of antibiotics (last four weeks). Patients with severe organ failure(s) or cognitive impairment were not included. From September to December 2014, we also contacted the patients in the substance abuse-project via telephone calls for inclusion, making two attempts to reach each patient: once during daytime and once in the afternoon. In this patient group, all parts of the study were conducted via the hospital outpatient clinic. In the group of admitted patients, all parts of the study were conducted during their stay at the hospital. A control group was recruited from consecutive patients admitted to the hospital from September to December 2014, with no history of alcohol overconsumption. This was specified as a present daily intake of less than 5 or 10 g per day for women or men, no history of intake of more than 20 g per day for longer periods, no history of prolonged binge drinking, and no history of daily alcohol intake. Regarding all patients, a faecal sample was required for inclusion in the present study. The study was approved by the Regional Committee for Medical Research Ethics (REK Sør-Øst; reference number 2013/2357), and conducted according to the Declaration of Helsinki. We obtained a written informed consent from all study participants.

Assessment of alcohol intake and nutritional status {#S0004-S2002}
---------------------------------------------------

We applied "Time line follow-back"^[31](#CIT0031)^ to assess the amount of alcohol intake. The instrument was used to capture daily alcohol use (unit for unit) for a period between 2 and 4 previous weeks. These data were applied as a basis for alcohol use over time, in accordance with the patients' recollection of alcohol intake prior to this 2--4 week period. The patients' nutritional status was evaluated using the screening tool Mini Nutritional Assessment (MNA)^[32](#CIT0032)^ and anthropometric measures (height, weight). Muscle mass was assessed by a Tanita BC-418 Segmental Body Composition Analyzer (TANITA Corporation, Tokyo, Japan). As a marker for muscle function, we measured the participants' handgrip strength by a dynamometer (Kern MAP, Kern & Sohn, Balingen, Germany). Biochemical markers included vitamins A, B1, B9, B12, C and D, hepatic and renal function tests, hematological status, iron levels, and electrolytes, and were measured as part of the hospital's routine analyses. Fecal levels of elastase were measured using a commercial kit (Human Pancreatic Elastase ELISA BS 86--01, Bioserv Diagnostics, Rostock, Germany). Based on elastase levels, patients were classified as having a normal exocrine pancreatic function (\>200 μg elastase/g feces), moderate exocrine pancreatic insufficiency (100--200 μg elastase/g feces), or severe exocrine pancreatic insufficiency (\<100 μg elastase/g feces).

Analysis of gut microbiota composition {#S0004-S2003}
--------------------------------------

Faecal samples were collected in empty plastic tubes (Sarstedt AG & Co, Nümbrecht, Germany), immediately frozen at minus 20°C, and transferred to minus 80°C within one week. Isolation of DNA, DNA sequencing and initial bioinformatics analyses were performed by Novogene (Beijing, China). Total genomic DNA was extracted using the CTAB/SDS method. DNA concentration and purity was measured on 1% agarose gels before DNA was diluted to 1 ng/μL with sterile water. All PCR reactions were carried out with Phusion® High-Fidelity PCR Master Mix (New England Biolabs, Ipswich, USA). The 16S V3-V4 region was amplified using 342F/806R as a primer set, and the resulting amplicons were visualized using SYBR green on a 2% agarose gel. Samples with a band between 400 and 450 base pairs (bp) were chosen for further experiments. Polymerase chain reaction products were mixed in equimolar ratios. Then, mixture PCR products were purified with Qiagen Gel Extraction Kit (Qiagen, Germany). Sequencing libraries were generated using TruSeq® DNA PCR-Free Sample Preparation Kit (Illumina, USA), and index codes were added. The library quality was assessed on the Qubit@ 2.0 Fluorometer (Thermo Scientific) and Agilent Bioanalyzer 2100 system. The libraries were sequenced on an Illumina HiSeq 2500 platform generating 250 bp-end reads.

Bioinformatics {#S0004-S2004}
--------------

After sequencing, bp-end reads were assigned to samples based on their barcode sequence, and then trimmed by cutting off the barcode and primer sequence. Paired-end reads were merged using FLASH (v1.2.7), ^[33](#CIT0033)^ and the merged reads were quality filtered to obtain high-quality reads using QIIME (V1.7.0).^[34](#CIT0034)^ The merged reads were compared with the gold reference database using the UCHIME algorithm^[35](#CIT0035)^ to detect and remove chimeric reads, resulting in a set of effective reads. Using UPARSE (v7.0.1001), ^[36](#CIT0036)^ we merged sequences with ≥97% similarity into the same Operational taxonomic unit (OTU). Representative sequences from each OTU were then used to annotate the OTUs using the RDP classifier (v2.2) and the GreenGene Database.^[37](#CIT0037)^ OTU abundances were down-sampled to the sample with the least sequences, and analysis of alpha diversity and beta diversity were all performed using this normalized dataset. Alpha diversity was measured using Shannon metrics calculated using QIIME (v1.7.0). Beta diversity analysis was performed using both weighted and unweighted UniFrac, calculated by QIIME. These distance matrices were used for clustering in R (hclust). Relative taxa abundances were obtained by dividing the count for each taxa by the total number of reads in their respective sample.

Analysis of short chain fatty acids (SCFAs) {#S0004-S2005}
-------------------------------------------

We investigated faecal SCFA content using methods previously described by Zijlstra et al., ^[38](#CIT0038)^ and modified by Hoverstad et al.^[39](#CIT0039)^ Briefly, faecal samples were vacuum distilled, and subsequently, gas chromatography of the distillates, using flame ionization detection, was used to quantify the SCFAs. We then calculated concentrations and percentages of the following SCFAs: acetic acid, propionic acid, iso-butyric acid, butyric acid, iso-valeric acid, valeric acid, iso-capronic acid, and capronic acid.

Predictive metagenomic analysis {#S0004-S2006}
-------------------------------

To investigate possible functional differences between patients and controls, we applied phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt), a computational method to predict the functional composition of a metagenome using marker gene data, and a database of reference genomes.^[27](#CIT0027)^ PICRUSt predicts which gene families are present and quantify them using the 16S data, based on similarities between the large number of sequenced bacterial genomes and those not sequenced. In the present case, we used the obtained OTUs from UPARSE as a marker gene, and re-annotated them using BLAST with the GreenGene database. The OTU count table was normalized against 16S copy number before calculating metagenomic scores for KEGG orthology (KO) terms.^[40](#CIT0040)^ These were further merged using the "categorize_by_function.py" script (to level 3). The resulting terms approximate the metagenomes of the patients, or in other words, which genes that are present in the bacterial genomes of the gut microbiota.

Statistical analyses {#S0004-S2007}
--------------------

Data were analyzed using SPSS version 18.0. Figures were made by using GraphPad Prism version 8. P-values of \<0.05 were set as a threshold for statistical significance. Continuous, normally distributed data, including demographical data, anthropometric data, and blood samples were analyzed using Student's t-test. Mann Whitney U-test was used to compare the test results of MNA and SCFAs, all of which had a non-normal distribution. Fischer's exact test was used to compare fractions of patients in danger of malnutrition (MNA), and patients with pancreas insufficiency. Differences in relative abundance at the phylum- and genus level were compared using Mann Whitney U-test, and operational taxonomic units with a relative abundance of \>0.001 (0.1%) were considered relevant. Correlation analyses were performed using Spearman\`s rho correlation test. Due to the explorative nature of our study, we did not correct for multiple testing. However, we did perform a complementary and validating additional test using linear discriminant analysis effect size (LEfSe).^[12](#CIT0012)^ Beta diversity was analyzed using one-way ANOVA, followed by Tukey's HSD test for weighted (takes into account amount of the different species) and unweighted (focuses only on the presence of different species) analyses.
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[^1]: ^1^MNA: Mini Nutritional Assessment. ^2^Patients with fecal elastase \<200 μg elastase/g feces.
